VZV | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

245 results for “VZV”

Rare Shingles Reactivation Reported Post-Shingrix Vaccination

NanoViricides Advances NV-387 for Herpes Zoster Treatment to Phase II Trials

FDA Grants Emergency Use Authorization to Seegene's Allplex Multiplex PCR Assay for Simultaneous Detection of Four Viral Pathogens

Brivudine Shows Promise in Treating Herpes Zoster, Meta-Analysis Suggests

Shingles Episodes Linked to 20% Higher Risk of Cognitive Decline, Brigham Study Reveals

Meta-Analysis Reveals Shingles Infection Significantly Increases Risk of Parkinson's and Dementia

FDA Approves Shingrix for Shingles Prevention in Immunocompromised Adults

GSK's Shingrix Prefilled Syringe Under Review by FDA and EMA for Shingles Prevention

Curevo's Amezosvatein Shows Zero Shingles Cases in Phase 2 Trial

QuidelOrtho's VITROS Syphilis Assay Receives FDA Approval to Combat Syphilis Epidemic

Page 1 of 3